Nkg2d Ligand Detection
Nkg2d Ligand Detection - Related Videos
05:24
Two Flow Cytometric Approaches of NKG2D Ligand Surface Detection to Distinguish Stem Cells from Bulk Subpopulations in Acute Myeloid Leukemia
0 Views •
Cited by 1 •
2021
We present two different staining protocols for NKG2D ligand (NKG2DL) detection in human primary acute myeloid leukemia (AML) samples. The first approach is based on a fusion protein, able to recognize all known and potentially yet unknown ligands, while the second protocol relies on the addition of multiple anti-NKG2DL antibodies.
05:13
Biolayer Interferometry Technology to Detect Interactions between Ligand and Analyte
0 Views •
2025
In this video, we demonstrate biolayer interferometry (BLI) technology to detect the intermolecular interactions between ligands and target analytes in real-time. BLI measures changes in the interference pattern of white light reflected off a layer of immobilized ligands on a biosensor surface as they interact with analytes in solution.
10:24
Detection of Ligand-activated G Protein-coupled Receptor Internalization by Confocal Microscopy
0 Views •
Cited by 2 •
2017
This protocol describes confocal microscopy detection of G protein-coupled receptor (GPCR) internalization in mammalian cells. It includes the basic cell culture, transfection, and confocal microscopy procedure and provides an efficient and easily interpretable method to detect the subcellular localization and internalization of fusion-expressed GPCR.
02:40
Ligand Binding Sites
0 Views •
2020
Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands. Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
02:51
Metal-Ligand Bonds
0 Views •
2020
The hemoglobin in the blood, the chlorophyll in green plants, vitamin B-12, and the catalyst used in the manufacture of polyethylene all contain coordination compounds. Ions of the metals, especially the transition metals, are likely to form complexes. In these complexes, transition metals form coordinate covalent bonds, a kind of Lewis acid-base interaction in which both of the electrons in the bond are contributed by a donor (Lewis base) to an electron acceptor (Lewis acid). The Lewis acid in...
FAQs
Surface abundance affects how strongly ligand-bearing cells can engage NKG2D on natural killer cells and cytotoxic T cells. Measurements of MICA, MICB, and UL16-binding proteins therefore provide more than a catalog of molecules: they indicate changes in tumor-cell immunogenicity. Comparing expression patterns can help researchers assess whether cancer cells remain visible to immune effector cells.
Molecular or staining-based measurements show whether NKG2D ligands are present, but they do not by themselves establish that ligand-receptor binding promotes immune-cell activation. Functional tests address that additional question directly. Using both approaches helps distinguish detectable ligand expression from biologically effective immune recognition, which is important when evaluating tumor responses or mechanisms that weaken antitumor immunity.
NKG2D ligand detection can reveal immune-evasion patterns in which cancer cells shed ligands or display fewer ligands at the cell surface. Either change may reduce effective interaction with NKG2D-bearing immune cells, even if related molecular signals remain detectable. Tracking these changes helps explain why a tumor may show altered immunogenicity and reduced susceptibility to immune-mediated recognition.
Flow cytometry, immunostaining, and molecular analysis provide complementary views of MICA, MICB, and UL16-binding proteins. Flow cytometry and immunostaining can characterize ligand-associated cellular patterns, while molecular analysis examines the corresponding molecular signal. Functional testing adds evidence about immune-cell activation. Comparing these readouts can clarify whether treatment-related changes affect expression, cellular distribution, or immune activity.
Researchers can measure ligand patterns before and after treatment to determine whether therapy changes tumor immunogenicity. Repeated assessment may identify increased or reduced expression, altered surface display, or evidence of ligand shedding. Pairing these measurements with functional tests shows whether observed molecular changes correspond to stronger or weaker activation of natural killer cells and cytotoxic T cells.
In cancer research, the results support studies of NKG2D-targeted immunotherapies by showing which tumors display relevant ligands and whether those ligands engage immune cells effectively. The same data can contribute to biomarker development for predicting antitumor immune responses. This makes ligand status useful for relating tumor characteristics to potential immune recognition and treatment response.